“Holistic TB Care”: India Starts Major Study Blending Ayurveda with Modern Medicine

Marking World Tuberculosis Day, India has launched a first-of-its-kind global clinical study to evaluate the integration of Ayurveda with standard tuberculosis treatment.

Announced by Union Minister Jitendra Singh, the initiative aims to combine traditional knowledge systems with modern biotechnology to improve patient outcomes through a holistic, patient-centric approach.

Study Design and Scope

The clinical study will enrol over 1,200 newly diagnosed tuberculosis patients across multiple leading institutions in India. It will assess Ayurveda as an adjunct to standard Anti-Tuberculosis Treatment (ATT).

Key parameters under evaluation include:

Nutritional recovery and body weight
Disease progression
Quality of life
Safety and treatment tolerability

The research is being conducted through collaboration between the Department of Biotechnology and the Ministry of AYUSH, following a Memorandum of Understanding signed in May 2022.

Focus on Holistic and Patient-Centric Care

Highlighting the need for integrated healthcare, Jitendra Singh said, “Modern science and traditional knowledge must come together for holistic management and better outcomes in tuberculosis.”

He noted that even after successful treatment, many TB patients continue to face challenges such as weakness, weight loss, and reduced quality of life—areas where supportive therapies like Ayurveda may offer benefits.

India’s Progress in TB Control

India has made notable progress in tackling tuberculosis, recording a 21% decline in incidence since 2015. By 2024, the rate dropped to approximately 187 cases per 100,000 population.

These gains have been driven by initiatives under the National TB Elimination Programme, including early diagnosis, universal drug susceptibility testing, digital adherence technologies, and strengthened patient care.

Addressing Persistent Challenges

Despite progress, tuberculosis continues to pose major challenges, including drug resistance, treatment toxicity, undernutrition, and long-term health complications.

The minister also highlighted links between TB and conditions such as diabetes, emphasizing the need for a multidisciplinary and comprehensive healthcare approach.

Scientific Validation Through Advanced Tools

The study aims to bring scientific validation to traditional medicine using advanced research tools, including immune profiling, metabolomics, MRI scans, and genomic analysis.

It also aligns with India’s broader “whole-of-science” and “whole-of-government” approach, integrating expertise across sectors to strengthen healthcare delivery and research.

Expanding India’s TB Research Ecosystem

India has been scaling up its TB research efforts through initiatives such as RePORT India and the Indian Tuberculosis Genomic Surveillance Consortium. These programs have contributed to global policy frameworks and enhanced the country’s response to drug-resistant TB.

The government continues to invest in diagnostics, vaccine development, and digital health technologies to accelerate progress toward TB elimination.

Emphasis on Community Participation

Jitendra Singh stressed that eliminating tuberculosis requires collective action beyond government initiatives. Community awareness, improved nutrition, and social support are critical to ensuring early diagnosis, reducing stigma, and supporting recovery.

Related posts:

India’s first holistic health Care Project & first Centre for Excellence in Robotics at Amrita Institute of Medical Sciences Goa to Expand All India Institute of Ayurveda Campus With Cancer Research Facilities India Digitises Traditional Medicine with AI-Powered Traditional Knowledge Digital Library Amrita Varsity to Launch Integrated Study Centre Dalmia Healthcare Starts Clinical Trial with its Ayurvedic Composition to Treat COVID-19